|
🐜
|
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study
14 auth.
M. Amato,
E. Portaccio,
B. Goretti,
V. Zipoli,
A. Iudice,
Dario Della Pina,
G. Malentacchi,
S. Sabatini,
P. Annunziata,
M. Falcini,
...
Monica Mazzoni,
M. Mortilla,
C. Fonda,
N. de Stefano
|
7 |
2010 |
7
🐜
|
|
🐢
|
IL-6 detection in multiple sclerosis brain
D. Maimone,
G. Guazzi,
P. Annunziata
|
7 |
1997 |
7
🐢
|
|
🐜
|
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".
89 auth.
R. Cervera,
M. Abarca-Costalago,
D. Abramovicz,
F. Allegri,
P. Annunziata,
A. Aydintug,
M. Bacarelli,
F. Bellisai,
I. Bernardino,
E. Biernat-Kałuza,
D. Blockmans,
K. Boki,
L. Bracci,
V. Campanella,
M. Camps,
...
C. Carcassi,
R. Cattaneo,
A. Cauli,
R. Cervera,
H. Chwalińska-Sadowska,
L. Contu,
J. Cosyns,
M. Danieli,
D. DCruz,
G. Depresseux,
H. Direşkeneli,
I. Domenech,
G. Espinosa,
A. Fernández-Nebro,
G. Ferrara,
J. Font,
M. A. Frutos,
M. Galeazzi,
M. García-Carrasco,
M. F. García Iglesias,
A. García-Tobaruela,
J. George,
A. Gil,
P. González‐Santos,
M. Grana,
A. Gül,
H. Haga,
M. de Haro-Liger,
F. Houssiau,
G. Hughes,
M. Ingelmo,
A. Jędryka-Góral,
M. Khamashta,
P. Lavilla,
Y. Levi,
M. López-Dulpa,
A. López-Soto,
H. Małdykowa,
R. Marcolongo,
A. Mathieu,
G. Morozzi,
N. Nicolopoulou,
C. Papasteriades,
G. Passiu,
I. Perelló,
P. Petera,
R. Petrovic,
J. Piette,
V. Pintado,
O. De Pità,
R. Popović,
G. Pucci,
P. Puddu,
E. de Ramón,
M. Ramos-Casals,
J. Rodriguez-Andreu,
G. Ruiz‐Irastorza,
J. Sánchez-Lora,
G. Sanna,
R. Scorza,
G. Sebastiani,
Y. Sherer,
Y. Shoenfeld,
A. Simpatico,
R. Sinico,
J. Smolen,
A. Tincani,
G. Tokgöz,
A. Urbano-Márquez,
C. Vasconcelos,
J. Vázquez,
J. Veronesi,
J. Vianna,
J. Vivancos
|
7 |
2006 |
7
🐜
|
|
🐢
|
Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1β and TNFα
D. Maimone,
C. Cioni,
S. Rosa,
G. Macchia,
F. Aloisi,
P. Annunziata
|
6 |
1993 |
6
🐢
|
|
🐬
|
Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy
I. Simone,
P. Annunziata,
D. Maimone,
M. Liguori,
R. Leante,
P. Livrea
|
6 |
1993 |
6
🐬
|
|
🐬
|
Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
D. Maimone,
P. Annunziata,
I. Simone,
P. Livrea,
G. Guazzi
|
6 |
1993 |
6
🐬
|
|
🦁
|
HIV‐1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P
P. Annunziata,
C. Cioni,
S. Toneatto,
E. Paccagnini
|
6 |
1998 |
6
🦁
|
|
🦁
|
Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium
P. Annunziata,
C. Cioni,
Riccardo Santonini,
E. Paccagnini
|
6 |
2002 |
6
🦁
|
|
🦁
|
High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients
P. Annunziata,
N. Volpi
|
6 |
1985 |
6
🦁
|
|
🐜
|
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE.
20 auth.
M. Galeazzi,
P. Annunziata,
G. Sebastiani,
F. Bellisai,
V. Campanella,
G. Ferrara,
J. Font,
F. Houssiau,
G. Passiu,
E. Garrido,
...
A. Fernández-Nebro,
L. Bracci,
R. Scorza,
P. Puddu,
A. Jędryka-Góral,
J. Smolen,
A. Tincani,
C. Carcassi,
G. Morozzi,
R. Marcolongo
|
5 |
2000 |
5
🐜
|
